Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-007567
Filing Date
2023-02-07
Accepted
2023-02-07 16:50:03
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4986
  Complete submission text file 0001209191-23-007567.txt   6472
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Issuer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Quinn William P. (Reporting) CIK: 0001724190 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39988 | Film No.: 23595785